Abstract | PURPOSE: MATERIALS AND METHODS: RESULTS: Of the 23 patients enrolled in the study, 22 completed the treatment. With regard to clinical stages, 82 % were diagnosed as IVA and 18 % IVB. Complete and partial response was observed in 82 and 18 %, respectively. Five-year overall survival, disease-specific survival, and locoregional control were 51, 70, and 72 %, respectively. No statistically significant difference was seen between the monthly regimen and the weekly plus biweekly regimen, although the latter resulted in longer survival and 88 % control. CONCLUSION:
|
Authors | Tatsuhiko Nakasato, Mitsuru Izumisawa, Akio Akahane, Koyo Kikuchi, Shigeru Ehara, Satoru Shoji, Shintaro Kogi, Harumi Mizuki, Yoshiki Sugiyama |
Journal | Japanese journal of radiology
(Jpn J Radiol)
Vol. 30
Issue 9
Pg. 752-61
(Nov 2012)
ISSN: 1867-108X [Electronic] Japan |
PMID | 22936237
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Taxoids
- Docetaxel
- Cisplatin
- Fluorouracil
|
Topics |
- Aged
- Aged, 80 and over
- Antineoplastic Agents
(administration & dosage)
- Carcinoma, Squamous Cell
(therapy)
- Chemoradiotherapy
- Cisplatin
(administration & dosage)
- Combined Modality Therapy
- Docetaxel
- Drug Administration Schedule
- Female
- Fluorouracil
(administration & dosage)
- Gingival Neoplasms
(therapy)
- Humans
- Infusions, Intra-Arterial
- Male
- Mandible
- Middle Aged
- Taxoids
(administration & dosage)
- Treatment Outcome
|